<DOC>
	<DOCNO>NCT00247039</DOCNO>
	<brief_summary>To determine clinical effect garlic prevent treatment patient chemotherapy relate febrile neutropenia.These patient high incidence infection routinely cover standard empiric therapy . Adding non- toxic possibly effective therapy may reduce risk infection , synergize empiric antibiotic treatment may lessen need broad spectrum severe side effect .</brief_summary>
	<brief_title>Garlic Patients With Febrile Neutropenia</brief_title>
	<detailed_description>Patients eligible randomized receive placebo garlic capsule chemotherapy course leukocyte recovery .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>FN patient expect least 5 day neutropenia eligible treatment garlic compound AST/ALT ≤ 3 time upper limit institutional laboratory normal . Total bilirubin ≤ 2 time upper limit institutional laboratory normal . BUN creatinine ≤ 3 time upper limit institutional laboratory normal . Newly diagnose well previously treat patient eligible . History clinically significant liver kidney disease . Patients anticoagulation therapy Coumadin exclude potential garlic interference metabolism . Patients receive concomitant chemotherapeutic treatment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>neutropenia</keyword>
	<keyword>fever</keyword>
	<keyword>garlic</keyword>
	<keyword>infection</keyword>
</DOC>